- Definitive Healthcare Corp. (NASDAQ: DH) demonstrates robust financial health, significantly outperforming its cost of capital.
- The company boasts an impressive Return on Invested Capital (ROIC) of 41.44% against a Weighted Average Cost of Capital (WACC) of 5.78%, yielding a strong ROIC to WACC ratio of 7.17.
- Definitive Healthcare consistently creates substantial shareholder value, highlighting its market leadership in the healthcare intelligence sector compared to peers.
Definitive Healthcare Corp. offers commercial intelligence solutions to the U.S. healthcare industry. A key measure of a company’s financial health is its ability to create value. This is often checked by comparing its Return on Invested Capital (ROIC) to its Weighted Average Cost of Capital (WACC).
ROIC shows how much profit a company makes from the money invested in its operations. WACC represents the average cost of that capital. If a company’s ROIC is higher than its WACC, it is effectively creating value for its shareholders. This signals a healthy and efficient business.
DH demonstrates exceptional performance with an ROIC of 41.44% and a WACC of 5.78%. This gives it an ROIC to WACC ratio of 7.17. This indicates that for every dollar of capital the company uses, it generates more than seven dollars in value, showing a highly profitable model.
When compared to its peers, Definitive Healthcare’s strength is clear. Most of its competitors are destroying shareholder value with negative ROIC figures. For instance, Thoughtworks Holding, Inc. (NASDAQ: TWKS) has an ROIC of -1.68%, and AvidXchange Holdings, Inc. (NASDAQ: AVDX) has an ROIC of -2.67%, both far below their capital costs.
Even the strongest peer, LifeStance Health Group, Inc. (NASDAQ: LFST), is not creating value. While it has a positive ROIC of 3.03%, this is significantly below its WACC of 9.53%. This contrast emphasizes Definitive Healthcare’s unique position in generating substantial returns relative to its competitors in the sector.
